The ATAC study on adjuvants in breast cancer. what kind of repercussions will it have on clinical practice?
Gamucci, T.
I Suppli di Tumori Official Journal of Societa Italiana di Cancerologia . 3(4): S16
2004
ISSN/ISBN: 2283-5423 PMID: 15206201 Document Number: 567730
Document emailed within 1 workday
Related Documents
Bravi, S. 2004: The ATAC study on adjuvants in breast cancer I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S15Baldini, E.; Prochilo, T. 2004: The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence? I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S79-S80
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Khalil, S.; Ceccarelli, F. 2009: Colorectal cancer after breast cancer: magnitude of risk in clinical practice and in the literature Tumori 95(1): 28-31
Okawa, T.; Ikeda, M.; Mikuriya, S.; Hashimoto, S.; Amino, S.; Horiuchi, J.; Matsuda, T.; Ebata, K.; Kaneda, K. 1985: A clinical study of radiotherapy with HCFU for advanced and recurrent breast cancers. Radiation and HCFU Study Group for breast cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(2): 131-136
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Dias, D.Spadoto.; Dias, Rério.; Nahás-Neto, J.; Nahás, E.Aguiar.Petri.; Leite, N.José.; Bueloni-Dias, Fávia.Neves.; Modotti, W.Pereira. 2014: Clinical and psychological repercussions of videolaparoscopic tubal ligation: observational, single cohort, retrospective study Sao Paulo Medical Journal 132(6): 321-331
Mamounas, E.P.; Budd, G.Thomas.; Miller, K.D. 2008: Incorporating the Oncotype DX breast cancer assay into community practice: an expert Q&A and case study sampling Clinical Advances in Hematology and Oncology: H&o 6(2 Suppl. 3): 1-8
Mamounas, E.; Budd, G.Thomas.; Miller, K. 2008: Incorporating the Oncotype DX breast cancer assay into community practice: An expert Q & A and case study sampling Clinical Advances in Hematology and Oncology: H&o 6(2): S1-S8
Fetting, J.H.; Siminoff, L.A.; Piantadosi, S.; Abeloff, M.D.; Damron, D.J.; Sarsfield, A.M. 1990: Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(9): 1476-1482
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Tominaga, T.; Nomura, Y.; Adachi, I.; Aoyama, H.; Nagao, K.; Mitsuyama, S.; Nakamura, Y.; Ogita, M.; Sano, M.; Takashima, S. 1994: Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 809-816
Yamada, K.; Kohno, N. 2007: Clinical study of bisphosphonates for bone metastasis in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 352-355
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82